capecitabine/methotrexate/vinorelbine regimen
Term · Oncology and biomedicine · MLC-T-ONC-012232
A regimen composed of capecitabine, methotrexate and vinorelbine that can potentially be used in the treatment of breast cancer.
| Identifier | MLC-T-ONC-012232 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Xeloda/methotrexate/navelbine regimen; capecitabine-methotrexate-vinorelbine regimen; Xeloda-methotrexate-navelbine regimen; XMV regimen; capecitabine/methotrexate/vinorelbine tartrate regimen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012232",
"term": "capecitabine/methotrexate/vinorelbine regimen",
"field": "Oncology and biomedicine",
"definition": "A regimen composed of capecitabine, methotrexate and vinorelbine that can potentially be used in the treatment of breast cancer.",
"synonyms": [
"Xeloda/methotrexate/navelbine regimen",
"capecitabine-methotrexate-vinorelbine regimen",
"Xeloda-methotrexate-navelbine regimen",
"XMV regimen",
"capecitabine/methotrexate/vinorelbine tartrate regimen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/capecitabine-methotrexate-vinorelbine-regimen/"
}
Record 4,107 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.